Topics
Astrocytoma | Treatment | Integrative medicine | Eflornithine
Home > Publications > Topics > Astrocytoma > Treatment > Integrative medicine > Eflornithine
Colman H, Lombardi G, Wong ET, Walbert T, Eoli M, Lassman AB,
Peereboom DM, Kizilbash SH, Kamiya-Matsuoka C, Pitz MW, Strowd RE,
Desjardins A, Kumthekar P, Mason W, Pellerino A, Soffietti R,
Butowski N, Forsyth PA, Hamza MA, Hau P, Lallana E, Nabors B,
Piccioni D, Uhlmann EJ, Welsh LC, Wen PY, Dietrich J, Wang C,
Levin VA.
STELLAR: Phase III,
Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus
Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.
J
Clin Oncol. 2025 Dec 1:JCO2501204. doi:
10.1200/JCO-25-01204. PMID:
41325560. Interventional study. ˍ